Recog nition of pathogens by imm une cells initiates the release o f numerous signali ng molecu les. includi ng cytokincs and eicosanoids. Here, we describe a simple procedure by which cicosanoids such as prostaglandin E, (PGE 2) . leukotrienc 8( LTB~) and u uomboxane 8 2 (Tx B 2 ) can be measured us ing commercial enzyme immunoassays (El As) in the supernatant of whole blood stimulated with inflammatory stimuli. This is illustrated for numerous stimuli. The kinetics by which lipopo lysaccharide (LPS) induces cyc looxyg cnasc (COX ).2 expression in this setup were determined by qua ntitat ive reverse transcrip tion polymerase chain reaction (RT-PCR). The cicosanoid respon se of the blood of 160 hea lthy volunteers to I ugrml LPS .....as measured.
I. Introduction
The potential of blood to release cytokines. e.g. intcrlcukin-t p (IL· l r' » or rumo r necrosis factor-c. in response to an inflammatory stimulus. e.g. endotoxin, has proven a useful measure or the immune status of patients with. e.g. mult iple s cl e ro s is (Beck .:I al., 19XK) . leishmaniasis (Frankcnburg and KI:lUS. I'N l l, (}0 22-17591031S _ see front matter C 2( 0) Elscvicr Science B.V. All rights rescrved. doi: I0,I0 16150022· 1759(03) First publ. in: Journal of immunological methods 277 (2003) , 1-2, pp. 53-63 Konstanzer Becau se of the role eicosanoids play in inflammation, pa in and fever. their prod uct ion is a target of pharmaceutical intervention. Alt hough acetyl-salicylic acid has been on the market for over 100 years, there is still research into mo re effecti ve and more selec tive inhibitors of cicosanoid release. However, their effects Oil isolated enzymes or cell lines have been reported to differ from the effects in vivo (Muc hcll et ul.. 1l)93; de Lcva l ct al., 200 I ).
Ex vivo stimu lation o f whole blood appears to reflect closely what happens in vivo. The immune cells are present in natural ratio s and can interact with each other. As no isolation procedure beyond the drawing of blood is requ ired, the assay is characterized by few preparation art ifacts and standardized performance. Volunteers are not exposed d irect ly to potential ly hazardous agents such as lipopol ysaccharide (LPS) as in the case of human experi mental endo toxemia. yet informati on about immune modulation under conditions of leukocytc acti vation or ovcractivetion can he obtained. The commercial enzym e immunoassays (EIAs) used do not require pr ior extrac tion of the cicosanoids for these measurem ents.
As described previously for lcukc triene formation (Fradin et al.. 19IN) . we used LPS and seven further " "'''. " (Glaser et al., 1995; Riendeau et al.. 2001 ; Bridean et al., 1996 : Blain ct al.. 2002 and has not been evaluated systematically with respect to determinin g modu lation of the eicosanoid response in the course of disease, although these lipid mediators play an important role in the immune response, Eicosanoids regulate vase-and bronchot onus. induce pain and fever and have Immunosuppressive or chemotactic properti es.
Constitutive cy cl oo xy ge nas e-t and inducib le cycloo xygcnase-z (COX. prostaglandin -endoperoxide synthase> convert arachidonic acid released from the cell membrane in response to stimulation to PGH 2 , which is then furthe r metabolised by other enzymes 10 var ious prostagtandin s. prosrecy clin and thrornb cxan cs (Fig. 1 ). In general, thromboxane A 2 (TxA 2), which is rapidly metabolised to inactive TxB 2 , and the leukotrienes (LTB 4 as well as pcpttdoleukotrienes LTCJ LTD 4 ) arc cons idered 10 bc proinflammat ory factors (R o la-P lcszczy nski . 19X1) ), while predom inantly anti-inflammatory characteristics are attributed to prostacyclin and prostaglandin E l (PG E 2 ) · immune stimuli to initiate eicosanoid release in whole blood. We characterized the kinetics of eicosanoid formation and their concordan ce with COX-2 expression. Furthermore. we estab lished normal values for the release of PGE 2 • LTB 4 and TxB 2 in response to a standard stimulus in 160 volunteers. We further investigated whether the effects o f in vivo treatment with COX inhibitors coul d be followed by ex vivo stimulation of their whole blood .
Me thods

2./. Differential blood COUllts
Differential blood count" were routinely performed on the blood of all volunt eers to rule out acute infections [Pentra 60. ABX Diagnostic s. Monrpe tlie r, France).
Characterization of eicosanoid release
The stimul i endotox in (LPS, I or 10 Ilglml) from Salmonella abortus equ i, lipoteicboic acid (LTA. 10 Ilglml) from Stap hylococcus aurvus, enterotoxins A and B from S. aureus (SEA and SEB, I ug/ml), heat-killed S. aureus, streptolysin 0 (SLO), complement facto r 5a (C5a), phorbo l myr istate acetate (PMA. 100 nglml) and phytohemagglutinin (PHA) were all from Sigma (Dciscnhofcn. Germany) and mumm y I dipept ide (MOP. I ug/ml) was from Hachcm (Heidelberg, Germany). The stimuli were added to 800 III RPM I 1640 (BioWhittaker, verviers. Belgium) supplemented with 100 IV penicillin, lOO ug/m l streptomycin (Gibco BRL. Life Technolog ies, Karlsruhc. Germany) and 2.5 IU/ml heparin (Liquemin w. Hoffinann LaRoche, Grcnzac h-Whylent Germany) and 200 III fresh. hepari nized who le blood in 1.5 ml polypropylene tubes (Eppendorf Hamburg. Gennany). After incubation at 37 "C and 5% CO 2 • cells were sedimented by centrifugation and supematants were frozen in aliquots at -80 "C until eicosa noid measurement. The concentrations of LTB 4 • PGE 2 and TxB 2 • i.e. the inactive metabolite of TxA 2 • we re measured by EIA (Cayman. SPI Europe. Gif sur Yvctte Cedex , France) according to the manufacturer 's instructions after appro priate dilution in EIA buffer supplied in the kits.
Measurement of cyclooxygenase expression
Fresh. heparinized whole blood ( I ml ) was added to sterile vac utainers (Sarsredr. Numb recht. Germany). which had been pre-f i lled with 4 ml RPMI 1640 supplemented with penicillin, streptomycin and heparin as above, and 10 ug/m l LPS from S. abort us equi or no stimulus. At diffe rent time po ints, RNA was prepared with QIAamp RNA Blood Mini Kit (Qiage n, WIden, Germany) accord ing to the manufacturer's ins truc tions. inc luding D NA d igest ion with the RNase-free DNase Set (Q iagen ). ]0.2 III RNA were reverse tra nscribed in a samp le vo lume of 20 III contai ning 2.5 Il M Oligo dT 1ft (Gibco BRL. custom primer), MgCJ 2 (5 mM). dN TP (I mM each), RNAse inhibitor ( 1 VIll I) . murine lc ukernia virus reverse transcriptase (2.5 U/Ill) in PeR buffer (all PE Applied Biosysrems, Weiterstadt . Gennany). Samples were incubated at 2 1 "C for 10 min. 42 "C for 15 min. 94 -c for 5 min and 5 "C for 5 min in a GeneAmp PeR System 2400 (PE App lied Bicsysrcms). A total of2 III cDNA was added to PeR master mix. containing 3 mM MgCI 2 , 400 nM sense, respectively. antisense primers for cycloo xygenase-2 pub lished in tnigucz et al. (199S) or housekeeping p rimers for glyceraldehyde-3-phosphate dehydrogenase (GAP-OH) (forward gaaggtg aaggtcggagtc , reverse gaagatggtgatgggatttc, TIB Molbiol. Berlin. German y) in Faststart LightCyelcr DNA Master SYBR G reen 1 (Roche Diagnostics, Mannhcim, Germany). pe R was perfor med in a Ligh tCyclcr T~Instrument, using thermal settings as follows: denaturat ion and activation of the polymerase al95 "C for 10 min and 50 cycl es of 95 "C for 0 s. 63 "C for 5 s and 72 "C for 20 s. A melting curve analysis was performed after PeR to ch eck the specificiry of the reaction. Fit point quantification was performed using LightCy cler3 software.
Volunteer study
Blood was drawn from a tota l of 160 healthy volunteers at the Universit y of Konstanz on 1\\'0 days. This occurred during the same two hours on both days. Fresh, heparini zed blood ( I ml). heparinized blood was added to sterile Vacutai ners (Sarstedt), which had been pre-filled w ith 4 ml RPMI 1640 supplemented with penicillin, streptomycin and hcparin as above. and I pg/m l LP$ from S. abortus equi.
After incubation for 24 h at 37°C and 5% eC h, cells were sedimented by centrifugation and supernarants were frozen in aliqucts at -80 "C until cicosanoid measurement as described. A variety of compounds including components from Gram-positive bacteria initiated the release of eicosanoids in human whole blood of five donors , of which the supematants were poo led before measurement (Fig. 2) . LTB 4 and Tx B 2 were measured after 4 h of incubation, whereas PGE 2 was measured after 24 h of incubation. Only streptolysin 0 and the compteOne tablet o f 400 mg ibupro fen (Ibupro fcn Klinge, Klingc Pharm a. Munich. Ger many}, 500 mg paracetamol (Benuron, Bene Arznci mittel. Munich. Germany), 200 mg phe nylbutazon (Ambene, Merckle, Blaubeuren , Ger many), 50 mg flurbiprofen (Froben, BASF Generics, Ismaning, Germany), 25 mg rolecoxib (Vioxx, MSD Sharp and Dohmc, Hear, Germany), 50 mg indomethacin (Amuno, MSD Sharp and Dohme , Hear, Ge rmany), 50 mg sodium diclofenac (Vcltaren. Novartis Pharma, Numbcrg, Germany), 500 mg acety lsalicylic acid (Aspirin, Baycr, Levcrkusen. Germany), 100 mg celecoxi b (Celebres. Scarlc, Nurnberg, Germany) or no medication was taken orally by one of the authors (TH, medical doctor, male, age 37, 85 kg) at 9 a.m. on different days with at least two days in between settings . Blood was taken before ingestion as well as 2 and 6 h later. lncubations were performed in Vacutainers as described above for 4 or 24 h. IL-\~w as measured using an ELlSA based on an antibody pair from Endoge n (Biozol, Eching, Germany) with rccomhinant hu IL-!I>, from NIBSC (Potte rs Bar, Herts. UK) as standard .
Results
3J Eicosanoid
Two group s of five vo lunteers (mean age 27.6 ±O.9 years, mean weight 77 ± 2 kg) each took 50 mg l1urbiprofen \ week apart. Blood was taken before ingestion and \, 9 and 25 h later, and stimulated with 10 ug/ml LPS for 24 h. This study was part of a clinical study performed at the University o f Konstanz according to the Declaration of Helsinki and Edinburgh and approved by the Ethical Committee of the University of Konstanz. Analysis of variance with Tukey post-test was perfo rmed using Graph Pad Prism 3.00 (Graph Pad Software, San Diego, CA), P<0. 05 was considered significant. Data are present ed as means ±S .E.M. of the number of blood donors indicated, calculated per ml blood, i.e. corrected for the dilution factor of5 in the incubation. Fig, 2 . Eicosanoid response to different stimuli. Release of PGE z , l](B~and LlB. in 20"10 whole blood incuba tions w ith blood from healthy volunteers stimulated with a variety of different stimuli, Eicosanoids in the supematants were meas ured by EIA; PGE 1 was measured after 24 h, T xB 2 and LTB., after 4 h. Data are normalized to LgS-mdu ced eico, anoid reteas c. Supernata nrs of five donors were poo led before measu rement . " ment factor C5a failed to induce signific ant amo unts of an y eicosanoid. The o the r stim uli empl oyed induc ed cha racteristic individual patterns of eicosanoid release. For instance , LTA induced more PGE 2 and TxB 2 than LPS, but less LTll" w hereas phor bol myris tate ace tate induced more Tx B 2 but less PGE 2 and LTB4 than the LPS stimulus. None of the stimuli induced mo re than I ng/ml LTE.. and PGI 2 (data nOI ShO"'l1).
Dose response of whole blood stimulated .....ith LPS
Whole blood from six healt hy donors was stimulated with I ng, 100 ng or 10 pg/ml LPS for 24 h. an d the three eicosanoid s PG E 2 , TxB 2 and LTB 4 were measured in the superna tams ( fig. J) . Compared to the larger quantities of the cycloo xygenase products PGE 2 and TxB 2 , of whi ch up to 100 nglml were detected, little leukotrien e B 4 • i.e. less than J ng LTBJ ml blood , was formed. 
Kinetics of whole blood response to stimulation with LPS
12'
LPS
In wh ole blood from six hea lthy blood donors incu bated in the prese nce of 10 ug/ml LPS, the timedependent release of LTB 4 , PG E 2 and TxB 2 ove r a period of 24 h was measured (Fig. 4) . PGE 2 form ation steadi ly increased unt il 24 h and was delay ed compared to LTB 4 and TxB 2 release. After 24 h incubation , the total amounts of PG E 2 and TxB 2 were app roximat el y eq ua l. LTB 4 peaked at 6 h. then levels decreased, though they remai ned elevated abo ve basal values at 24 h. TxB 2 levels remained stable around 60 nglml between 8 and 24 h.
Kinetics of cyctooxygenase expression in response to stimulation with 10 J1g/ml LPS
Expression of CO X-2 mRNA in response to sti mulat ion w ith LPS was quantified ove r 24 hand normalized to GAP-DH expression (Fig. 5) . Interestingl y, the CO X-2 exp res sion cur ve showed two peak s. the ea rlier one co rrelating w ith the ea rly TxB 2 peak, ind icating that COX-2 ex pression is the pacemaker for Tx B 1 release and that the early TxB 2 peak doe s not result from basa l CO X-J ac tivity. PG E 2 prod uction kinetic s shown abov e were not mirrored in the curve, indicati ng that ano ther enzyme is the pacemaker for its release. Although the four dono rs reacted on different levels. the shapes o f the curves were similar for all four do nors . PGE 2 and Tx B 2 release were measured in sa m ples ru n in lPS. Twen ty percent human whole blood was incubated in the presen ce of I flg/ ml lPS for 24 h. Eicosanords were determined in the supem atnnts 11)' EIA. Data are box -and-whis kers plot, for 160 blood donors , i.e. the boxes show the 25th and 75th percL'Iltile; the horizontal line in the box shows th e median value; the whiskers show the highest and the lowest va lu('s; CV is the coefficien t of variance , Basal release of cicosano id.' in COll1rvl incuba tions were 4 0:tO.17 nglm l PG E 2. O.2S±O.03 ngim! LTH4 and 2.1:to. I:! ng/ml TxB! .
The response of blood from 160 healthy volunteers at the University of Konstanz is displayed as a box and whiskers plot (Fig. 6 ) . The average age of the group was 30.2± O.9 and the sex distribution was 75 female/SS male. The release of PG~and TxB 2 in the blood of females (16.9 ±1.6 ng/ml PGE 2 and parallel after 24 h incubation (data not shown). Interestingly. the do nor with the greatest COX-2 expr ession was not the do nor with the highest PGE 2 or TxB 2 production. ,~~s õ as 77.8±5.3 ng/ml TxB 2 ) was slightly less than in the blood of males (20.9 ± 1.6 ng/ml PGE 2 and 99.4 ±5.9 ng/ml TxB 2 , both p<O.05 , Ma nn-Whitney test), whereas the release of LTB 4 was the same in blood from males (l.5 ±O.1 ng/ml) and females ( 1.4±O.1 ng/ml, n.s.), The coefficients of variation (CV) of cicosanoid release (76% for PGE 2 , 64% for LTB 4 and 57% for TxB 2 ) were slightly higher than for the release of turner necrosis factor a (50%) or IL. 10 (44%, data not shown), indicating that the interindividual differences are slightly greater for eicosanoid release than for cytokine release.
Response afblood fro m 160 heallhy vo lunteers to stimulation with 1 pg/ml LPS
Effects of the ingestion of cycloaxygenase inhibitors on the ex vivo eicosanoid response to LPS
One of the authors took onc standard dose of each of the listed drugs. All drugs were well tolerated and no side effects were reported. None of the drugs had significant effects on differential blood cell counts (data not shown). Control values were taken on three days at the beginning, middle and end of the study. Blood drawn before and at 2 h as well as 6 h after drug ingestion was stimulated with I ug/ml LPS. LT8 4 and TxB 2 were determined in the supcrnatanrs after 4 h incubation and PGE 2 was measured after 24 h (Table I) . Values were normalized to the eicosanoid release at the time point before drug ingestion on the respective day. The different drugs had different potencies and different duration of action. For instance, acetyl-salicylic acid, paracetamol and rofecoxib were only able to reduce LPS-induced PGE 2 release by less than a third, while ibuprofcn had a strong short-term effect, but LPS-induced PGE 2 had returned to normal values within 6 h of ingestion of the tablet. Flurbiprofen still had the strongest effect of all drugs on PGE 2 release 6 h after ingestion. In general , the find ings regarding the inhibition of PGE 2 release were mirrored by TxB 2 release, which was to be expected. as both are downstream products of COX. Some drugs also affected LTB 4 levels and the lipoxygenase system (Table I ). However. none of the drugs had significant effects on IL-l~>, release.
To con firm the findings described above, two groups of five healthy volunteers each took one tablet of 50 mg flurbiprofen. Blood was drawn before (0 h), and 1, 9 and 25 h after ingestion. No side effects were reported and there were no effects on the differential blood cell count as compared to values taken 2 weeks beforehand to establish the diurnal changes (data not shown). Pturbiprofen was very effective in reducing LI'S (10 pg/ml) induced PGE 2 and TxB 2 release within I h of ingestion (Fig. 7A and Bl. This effect held for 25 h regarding r GE 2 production, though TxB 2 values had returned to normal values within 25 h. These results indicate that flurbiprofen might additionally act on an enzyme further downstream from cyclooxygenase in the pathway of PGE 2 pro- Onc author took one standard dose (shown in mg) of different cyclooxygenase inhibitors at least 2 days apart. Blood was taken before inge<;tion as well as 2 and 6 h later and stimulated with I Jlg/ml LPS. Eicosanoid" were measured in the supcrnatants by EIA (PGE2 after 24 h, LTB4and TxB 1 alter 4 h incubation). tL-II\ was measured by ELlSA after 24 h incubation. Mediator release before ingestion was set 10 100%. Control values were taken on three different days and are shown a, means±S.E.M. cell populations do not cons ider transcellular activelion processes and protein binding which might occu r in vivo and may be altered in the course of disease. However, tbis is con trolled ill the whole blood assay described here. Further benefits ofthis test are thut in our experie nce the sterile vacutaincrs can be pre-fi l led with medium and the LPS stimulus and stored for at least 2 years without losing potency, so also limiting day to day variability and the time required to perfor mthe assay.
Moreover. the cicosanoid conce ntrations in the supe rnatants can now be measured by non -radioactive commercially avai lable EIAs. Th e supematants can be collected and stored at -80 Q C unti l measurement and. furthermo re. cytokine release capacity can also be measu red using the same supcmatants. thereby permitting easy and exact asse ssment of corre lations. The relatively high concent rations of LPS used in the assay (I or 10~lg!ml) induce fairly high levels of eicosanoid release in blood from healthy patients without being toxic, so facilitating their detection with this meth od and maki ng pri o r ex tractio n pro cedures unnecessary. The LPS concentrations also allow dctcction of potentially lower levels of eicosanoid release in immunologically challenged patient blood as well as under pharmacological cyc loox ygenase inhibi tion. This method could also be adapted for immune mon-... (Fig. 7C ) . A variety of inflamm atory stimuli were shown to induce characteristic patterns o f cicosanoid release. Further investigation s on the pyrogenic capacity of other inflammatory stimuli may elucidate their role in the inductio n of fever and pain. for instance by means of PGE 2 induction. This has been shown indirectly in vivo for endotoxin, as pretreatment of subjects with the cycloox ygenase inhibitor ibuprofen before administration of Escherichia coli LPS markedly attenuated flu-like symptoms. fever, tachycardia increased metabolic rate and the stimulation of stress hormone release. an d the subjects co uld not di stin gui sh between administration o f endotoxin and saline as could the positive con trols who received endo toxin but no ibuprofen IRO:\'haug et al.. IQ88). The importance of eicosanoids for the production and physiological action of other mediators of inflammation is increasingly recognized (Dc sscin et al.. 1986; Akama et al., 1990; Rola-Plcszczynski and Stankova. 19Q2; Saner and Ila rtung. 199-') . However. within the network of pro-and anti-inflammatory med iators. little attention has been paid to the possible interactions of cytc kincs with eicosanoids or the potential coregulatory mechanisms implied by correlations of eicosanoid and cytokine levels in the serum of patients. Such interactions can also be studied using this model. both at the level of COX -2 indu ction and cicosanoid release.
The quantitative reverse transcription polymerase chain reaction (RT-PCR) for COX-2 implies that the rate of production of TxB 2 in response to LPS is limited by COX-2 expression. whereas another mech anism co ntro ls the rate o f PGE z production .
Increased levels of COX-2 expression have been reported in the synov ial tissue o f patients with both rheumatoid arthritis and ostcoarthritis. as well as in some tumor tissues. and may play a role in the pe thogenes is o f Al zheimer 's di sease (Uin7 and Bnme . 19(9). The possibility of COX-2 mRNA qua ntification may be used to exp lore the role of COX-2 expression and its correlation with disease severity in d ifferent tissues and diseases. As COX-2 mRNA was already induced \ h after stimulation with lPS. the whole blood cicosanoid response assay does not pennit the discrimination of COX-I from COX-2 activity.
The relatively narro w d istribution of eicosanoid release levels induced in a large number of healthy individuals (11= 160) suggests that reference values might be establis hed for this type of reaction performed under standardized con ditions. Higher generation of TxB 2 in blood from male s in comparison to blood from females is consistent with data reported previously in a smaller number of volunteers {Hanscn er al.. 19:\9).
Furthermore, the clear effects of a number of different cyclcoxy genase inhibitors taken in vivo on the eicosanoid response ex vivo indicate that this method is sufficiently sensitive to capture the modulation o f the eicosanoid respon se in the course of disease or as a result o f the use of medication. Such a study is curren tly underway, investigating the effects on inflammatory parameters. including eicosano id release. of periopcrauve filgrastim treatment of patients undergoing majo r abdominal opera tions. The different cyclooxygenasc inhibitors employed appa rentl y had di fferent po tencies rega rd ing the inhibition of cyclooxygenase activity, although the data from this experiment in one volunteer should not be ove nnterpreted . This may be a function o f the concentrations employed though these were standard tablets. More probably. differ ing cfflcacies in suppressing prostanoid release stern from their different modes of action, whethe r thei r effects are reversible and from their half-life in the scrum. Althou gh acetyl-salicy lic acid irreversibly inhibits cyclooxygenase by acetylation of a single serine residue (Roth cl al.. 1(75) , its half-life in the serum seems to be too short to also acetylate newly induced COX-2. Ibuprofen inhibits COX by substrate com petition with arachidonic acid (Rome and lands. 1975 ) . In the presen t study it effec tive ly inhibited PGE z release 2 h after ingestion, though this effect was no longer observed 6 h after ingestion. The observation that celecoxib was more potent than rofecoxib is in line with data attributing a greater COX-V COX-I ratio to rofecox ib (Riendeau et al., 2001) . Flurbiprofen and indom ethac in block the metabolism of arachidonic acid by interacting with the bind ing site of arachidonic acid to the cyclooxyg enase (Mancini er al., \(97) . Both substances effectively inhibited cyclooxygenase activity 2 and 6 h after ingestion . Th is was confirmed in another study in which ten healthy vo luntee rs took one 50 mg tablet of flurbiprofen and LPS-inducible eicosan oids and IL-I B were measured. Flurbiprofen very effectively decreased LPS-induciblc PGE 2 and TxB 2 though nol IL-H~release. This effect still held 25 h alter intake for PGE 2 although TxB 1 release had returned to normal levels . Th is indicates that flurbiprofcn may also act on an enzyme further downstream in the production of prostaglandins .
Taken togethe r, the standardized human whole blood mode l assessing Ll'Svinduciblc cic osano ld release promises to be a simple in vitro and ex vivo measure of a rele vant parameter of the immune system. The broad app licability, similar to LPS-inducib lc whole blood mono kine release and staphy lococcal enterotox in B-inducible whole blood lymphok ine release, will permit a broad range of studies .
